ADIPOQ and Alzheimer disease: Despite its observed neuroprotective effects in cell-based and animal experiments [3,18,21,22,23,24,25], the role of adiponectin in the pathogenesis of AD in humans remains controversial, with some studies even suggesting its possible deleterious effects in amyloidogenesis [22,28,29,30,31].